Sunesis Pharmaceuticals
| Region | Nordamerika |
| ISIN | US8673288747 |
| Sektor | Biotechnologie |
| Website | https://www.sunesis.com/ |
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives.
| Titel | Autor | Datum |
|---|---|---|
|
Risikoarmes "Peak Play" mit Multibagger-Potenzial
|
sharedeals | translation missing: de.datetime.time_ago_in_words.almost_x_years |
| Titel | Datum |
|---|---|
| MISC a buy after getting approval for ammonia-fuelled tanker - MBSB IB | vor ungefähr einem Monat |
| MISC, SHI get BV's nod for 'world's first' ammonia-fueled LR2 tanker powered by PEMFC | vor ungefähr einem Monat |
| MISC, Samsung Heavy Industries get class approval for world's first ammonia-fuelled LR2 tanker design | vor ungefähr einem Monat |
| Stock Today: MISC Dips Amid Mixed Half-Year Results | vor ungefähr 2 Monaten |
| MISC's First Half Earnings Were Within Expectation | vor ungefähr 2 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Suedzucker (1 Artikel) | |
| Stockholm IT Ventures AB (1 Artikel) | |
| Tahoe Resources (1 Artikel) | |
| Telit Communications (3 Artikel) | |
| Alle anzeigen | |